Lv1
50 积分 2025-11-30 加入
Development of potent JAK1/2 PROTAC degraders for the treatment of inflammatory bowel diseases
6天前
已完结
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2
1个月前
已完结
Jaktinib (JAK1/2 inhibitor): A momelotinib derivative with similar activity and optimized dosing schedule
1个月前
已完结
New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach
6个月前
已关闭
Efficacy of inhaled corticosteroids in asthma
6个月前
已完结
Identification of a Potent Janus Kinase 3 Inhibitor with High Selectivity within the Janus Kinase Family
6个月前
已完结
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors
6个月前
已完结
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans
6个月前
已完结
Development of Selective Covalent Janus Kinase 3 Inhibitors
6个月前
已完结
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia
6个月前
已完结
皖公网安备34019202002308
